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Abstract:  
 
Objective 
 
This study analyzed the cost-effectiveness of delivering alcohol screening, brief intervention, and 
referral to treatment (SBIRT) in emergency departments (ED) when compared to outpatient 
medical settings. 
 
Methods 
 
A probabilistic decision analytic tree categorized patients into health states. Utility weights and 
social costs were assigned to each health state. Health outcome measures were the proportion of 
patients not drinking above threshold levels at follow-up, the proportion of patients transitioning 
from above threshold levels at baseline to abstinent or below threshold levels at follow-up, and 
the quality-adjusted life years (QALYs) gained. Expected costs under a provider perspective 
were the marginal costs of SBIRT, and under a societal perspective were the sum of SBIRT cost 
per patient and the change in social costs. Incremental cost-effectiveness ratios were computed. 
 
Results 
 
When considering provider costs only, compared to outpatient, SBIRT in ED cost $8.63 less, 
generated 0.005 more QALYs per patient, and resulted in 13.8% more patients drinking below 
threshold levels. Sensitivity analyses in which patients were assumed to receive a fixed number 
of treatment sessions that met clinical sites’ guidelines made SBIRT more expensive in ED than 
outpatient; the ED remained more effective. In this sensitivity analysis, the ED was the most 
cost-effective setting if decision makers were willing to pay more than $1500 per QALY gained. 
 
Conclusions 
 
Alcohol SBIRT generates costs savings and improves health in both ED and outpatient settings. 
EDs provide better effectiveness at a lower cost and greater social cost reductions than 
outpatient. 
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1. Introduction 
 
The physical, psychological, and social harms of substance abuse represent an important public 
health problem. The annual total estimated social cost of substance abuse in the United States is 
$510.8 billion (Miller & Hendrie, 2009). Screening, brief intervention, and referral for treatment 
(SBIRT) for alcohol has been shown to be clinically effective at identifying and ensuring 
treatment for people who consume above guidelines for low risk consumption but who would not 
be considered dependent (Heather, 1995 and Vasilaki et al., 2006). Referral to treatment helps 
address the treatment needs of people at the upper end of the risk continuum, including those 
dependent on alcohol. 
 
Analyzing the cost-effectiveness of SBIRT in different medical settings is a timely topic. The 
integration of substance abuse services into general medical care is growing (Buck, 2011). In 
addition to the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA), 
several other agencies have expressed the need to expand SBIRT services. The U.S. Preventive 
Services Task Force recommends that clinicians provide alcohol screening and brief intervention 
(SBI) to adult patients (Moyer, 2013). The Institute of Medicine, the Office of National Drug 
Control Policy, and the National Prevention Council have called for the integration of services 
designed to address substance misuse into primary care (Padwa et al., 2012). The American 
College of Surgeons Committee on Trauma requires that level I and II trauma centers screen for 
alcohol misuse, and level I trauma centers provide brief interventions (American College of 
Surgeons Committee on Trauma, 2007). 
 
Extensive literature shows that alcohol SBI is effective in primary care settings, yet many SBIRT 
implementation efforts have been conducted in emergency departments (EDs). In light of the 
current budget constraints and limited health care resources, it is important to understand the 
costs and effects of SBIRT delivery in these two settings. Policy makers might have to prioritize 
SBIRT delivery in the most cost-effective setting, and to do this they need information on the 
relative value for money of implementing SBIRT in each setting. 
 
While there is substantial literature on the costs and benefits of alcohol dependence treatment, 
there is a lack of economic studies focusing on alcohol SBI in medical settings (Kraemer, 2007). 
The lack of strong evidence for the cost-effectiveness of alcohol SBI is also mentioned in a 
recent cost-effectiveness review of SBI by Latimer, Guillaume, Goyder, Chilcott, and Payne 
(2010). In his review of economic studies of alcohol SBI in medical settings, Kraemer identified 
15 studies; however, four of them were only partial economic evaluations (i.e., they were cost 
analyses that did not take the health outcomes of a program into account). These studies are 
useful for program planning but do not indicate whether health outcomes are worth the costs and 
cannot be used to help with the allocation of scarce resources. Most studies lacked 
methodological rigor, which is consistent with the findings reported in a review by Barbosa, 
Godfrey, and Parrott (2010). In addition, Kraemer (2007) only found two economic evaluations 
of alcohol SBI in EDs. To our knowledge, no study has compared cost and effectiveness across 
settings. An extensive literature suggests that alcohol SBI is effective in some medical settings, 
particularly primary care (Chick et al., 1988, Fleming et al., 1997a, Fleming et al., 2007, 
Gentilello et al., 2005, Gentilello et al., 1999, Marlatt et al., 1998 and Miller and Sovereign, 
1989), but it may not always result in health care cost savings (Bray et al., 2011 and Latimer et 
al., 2010). Decision makers contemplating whether to implement SBIRT require guidance on 
what outcomes would be expected and what resources are required to achieve those outcomes. 
Cost-effectiveness analysis (CEA) quantifies the trade-off between costs and outcomes and uses 
nonmonetary measures of outcomes, such as drinking and quality of life. Thus, CEA helps 
decision makers by identifying strategies that represent good value for money (Drummond et al., 
2005 and Gold et al., 1996), and interventions that should be reimbursed from collective funding 
(Taylor, Drummond, Salkeld, & Sullivan, 2004). 
 
Since 2005, SAMHSA has funded six cohorts of grantees to implement SBIRT. Under this 
program, grantees screen and provide appropriate feedback, intervention or treatment to all 
individuals presenting for care, but not specifically seeking treatment for substance use, in 
selected medical settings, such as primary care clinics, trauma centers, and EDs. The current 
study presents the results of a CEA of the cross-site evaluation of the SBIRT initiative on the 
first cohort of seven grantees. Although administration varied across providers, typical 
procedures were as follows. The two common alcohol screening tools used were the Alcohol, 
Smoking and Substance Involvement Test (ASSIST) (Ali et al., 2002 and Humeniuk et al., 2010) 
and the Alcohol Use Disorders Identification Test (AUDIT) (Reinert and Allen, 2002 and 
Saunders et al., 1993), administered by a general practice nurse or behavioral health specialist. 
Brief interventions (BIs) were time-limited (15 min or less) and delivered using a motivational 
interviewing approach or other recognized method by a behavioral health specialist. Brief 
treatments (BTs) were scheduled counseling sessions with a behavioral health specialist. Referral 
to treatment (RT) was the act of making an appointment for specialist treatment, usually at 
another location. 
 
The analysis compares SBIRT delivery in two common settings: ED and outpatient. ED includes 
emergency departments and trauma centers, and outpatient includes a variety of clinics, such as 
Federally Qualified Health Centers (publicly funded general health care facilities providing 
primary health care in low-income areas) or hospital outpatient clinics. 
 
2. Methods 
2.1. Overview 
 
In CEA, the costs and consequences of at least two strategies (i.e., SBIRT delivery in outpatient 
and ED settings) are compared, and the results can help with understanding the value for money 
of each strategy (Drummond et al., 2005 and Gold et al., 1996). Health benefits associated with 
the strategies being compared can be measured and valued using natural units of outcome (e.g., 
reduction in risky alcohol consumption), or they can be measured and valued using generic 
measures of health-related quality of life, such as quality-adjusted life years (QALYs). QALYs 
incorporate the value individuals place on their health, called utilities, and are a widely used 
measure of health benefits that allows a comparison between different health care interventions 
that compete for the same pool of resources. 
 
The CEA used a decision analytic tree model following a cohort simulation approach. Data were 
observational and administrative, supplemented by survey data and the literature. Alcohol 
consumption and costs were assessed at baseline and 6 months after baseline. Separate analyses 
were conducted for two analytic perspectives. The provider perspective includes the costs to 
those delivering services. The broader social perspective includes costs to society: health care 
utilization—including the provider of SBIRT, criminal activity, automobile accidents, and lost 
income. All phases were conducted with the approval of an institutional review board protecting 
human subjects’ interests. 
 
2.2. Population 
 
The analysis considered 9835 SBIRT screen positive patients. The characteristics of the baseline 
population are presented in Table 1. Compared with the outpatient setting, the ED setting had 
statistically significantly higher mean age (37 vs. 31 years) and greater proportions of males 
(61% vs. 54%), alcohol users (75% vs. 62%), and users of alcohol and other substances (29% vs. 
27%). To capture variations between the settings this study adopted a pragmatic naturalistic 
design and did not adjust for those differences. 
 
 
 
The current study focused on SBIRT for alcohol-related problems. However, the program also 
included SBIRT for other psychotropic substances. Among the baseline sample, 39% of patients 
consumed drugs in the past 30 days at baseline. Twenty nine percent consumed both drugs and 
alcohol, and about 74% of people using drugs also used alcohol. The study does not exclude 
individuals with drug consumption at baseline. As shown in Table 1, the number of baseline drug 
users in the two settings was balanced (p = 0.4). 
 
2.3. Decision tree 
 
Decision trees are simple models where patients’ health states are clearly defined and time is not 
modeled explicitly. The model tracks the expected outcomes and costs of patients screening 
positive for drinking above the guidelines and receiving SBIRT services (Fig. 1). 
 
 
 
The health states, defined in the form of baseline and follow-up drinking categories, capture the 
effectiveness and cost-effectiveness of brief interventions in preventing unhealthy drinking and 
promoting low risk drinking levels, including abstinence. Each health state has associated 
utilities and social costs, as described below. SBIRT screen-positive patients in each setting were 
classified into three drinking categories: abstinent, below threshold, and above threshold. 
Abstinent refers to no consumption during the past 30 days, and threshold is defined as drinking 
five or more drinks in one sitting or four or fewer drinks in one sitting and feeling high in the 
past 30 days. Drinking above the threshold comprises people consuming at levels that pose some 
risk to health, including hazardous and harmful levels (e.g., Higgins-Biddle et al., 2009 and 
Humeniuk et al., 2010). Follow-up drinking categories are conditional on baseline drinking 
because previous drinking is associated with current health ( Rehm et al., 2003). Patients that 
were in abstinent or low threshold states at follow-up and in above threshold state at baseline 
were classified as new abstinent and new below threshold at follow-up, respectively. The number 
of patients in each category at baseline and follow-up informed the transition probabilities 
between the different states, for each setting. These probabilities were used to calculate the 
number of patients in each state of the model. 
 
2.4. Data 
 
2.4.1. Health states 
 
Health state measures were from the Government Performance and Results Act (GPRA) data 
(Service Accountability Improvement System, 2011). GPRA data were entered by program staff 
at baseline, 6-month follow-up, and discharge from the program as part of the requirements for 
receiving grant funds. These data provided information on baseline and follow-up drinking for 
each setting to capture the association between SBIRT and drinking behavior and classify 
patients into the health states of the model, which in turn informed the effectiveness component 
of the CEA. The GPRA lacked information on the quantity of drinks and information that would 
allow gender-specific drinking states to be calculated. GPRA includes items regarding the 
number of days during the past 30 that patients used any alcohol and the amount of times 
patients consumed five or more drinks in one sitting or four or fewer drinks in one sitting and felt 
high. The number of patients in each category at baseline and follow-up, by setting, was 
informed by intake and 6-month follow-up GPRA data, respectively. 
 
2.4.2. Health state utilities 
 
QALYs incorporate changes in quality of life (morbidity) by using a set of values or weights 
called utilities, one for each possible health state, which reflect the relative desirability of the 
health state (Drummond et al., 2005). The conventional scale for utility values used to calculate 
QALYs ranges from 0 (death) to 1 (perfect health). The relative desirability of outcomes is 
measured using the von Neumann–Morgenstern utility theory (von Neumann & Morgenstern, 
1944), where utilities are measured under uncertainty, such as in the standard gamble approach 
(Holloway, 1979). Utilities can also be measured under certainty using a choice-based approach, 
such as the time-trade-off (Torrance, Thomas, & Sackett, 1972). To our knowledge, only two 
studies have used a revealed-preferences approach to measure utilities for different health states 
that describe the spectrum of levels of alcohol consumption (Kraemer et al., 2005 and Petrie et 
al., 2008). 
 
Utility values for each of the five health states of the model were derived from a study of the 
utility of different drinking states for a U.S. population that used the standard gamble technique 
from a clinic/community sample (Kraemer et al., 2005). The mean utility values (standard 
deviation) used for each state were: abstinent 0.93 (0.15), new abstinent 0.83 (0.24), below 
threshold 0.88 (0.22), new below threshold 0.85 (0.26), and above threshold 0.75 (0.29). 
Abstinent has the highest utility score, followed by below threshold. Above threshold has the 
lowest utility. New abstainers and below threshold drinkers that were drinking above threshold at 
baseline have lower utilities than those who were abstinent or below threshold at baseline. In 
addition, new abstainers have a lower utility than new below threshold drinkers, which can be 
because those who abstain now had more problems in the past and so still have lower utility, 
or/and reduced drinking is a better outcome than abstinence. The finding that those with more 
serious past problems had a lower utility than those with less serious past problems is consistent 
with the only other study that reported utility levels for different levels of alcohol consumption 
(Petrie et al., 2008). 
 
2.4.3. Social costs 
 
To collect data on social costs events (e.g., nights in jail) for the 6 months before and 6 months 
after SBIRT services, the research team conducted a separate survey of a subsample of patients 
(Bray et al., 2007). The 6-month time frame captures relatively rare events (e.g., automobile 
accidents) and matches the time frame of the GPRA data. A random sample of sites was drawn 
using probability proportionate to size sampling, so that larger sites had a higher probability of 
being selected. The survey provided 2210 unique baseline interviews, of which 865 were 
positive screens and thus used in the current study. Survey records were weighted to make results 
representative of the patients exposed to SBIRT. In a first stage, patients were weighted to the 
full sample of patients from each specific setting. In a second stage, site-level patient flows were 
weighted up to the grantee level. There were 1258 weighted observations used to calculate 
socials costs by drinking category. 
 
Health care utilization was measured by the number of times patients received ED and outpatient 
treatment for a physical complaint or a behavioral (substance abuse/mental health) problem. 
Criminal justice costs were measured by the number of arrests and nights incarcerated. 
Automobile accidents were measured by the number of car crashes. A monetary valuation of the 
social outcomes was assigned by multiplying the unit costs of each outcome by the frequency of 
events. Unit costs with the exception of wages were retrieved from the peer-reviewed literature. 
ED cost estimates for physical and behavioral problems came from French and Martin (1996), 
outpatient costs for behavioral problems came from Roebuck, French, and McLellan (2003), 
arrest costs came from Zarkin, Dunlap, Hicks, and Mamo (2005), incarceration costs came from 
Stephan (2004), and automobile accident costs came from Blincoe et al. (2002) The unit cost 
calculation for an episode of driving under the influence of alcohol was based on several sources 
(FARS, National Highway Traffic Safety Administration, 2007 and Miller et al., 1996). Absence 
from work used patient’s self-reported annual income and the number of hours worked during 
the previous week (estimated directly from the patient survey). The overall change in social costs 
after SBIRT delivery was calculated for each drinking state and is presented in Table 2. Social 
costs changes were attached to the health states and differ between settings as a result of different 
distribution of patients between the health states. 
 
 
 
2.4.4. SBIRT costs 
 
SBIRT treatment costs were defined as the marginal costs of each SBIRT component (screening, 
BI, BT, and RT) for the ED and outpatient settings (Bray et al., 2014). During observational site 
visits to a sample of SBIRT sites, trained evaluators observed practitioner–patient interactions 
and recorded the time required to provide each SBIRT component. Observers timed 110 
screenings, 45 BIs, 11 BTs, and 12 RTs. Activities were categorized as direct service delivery, 
support of direct services (e.g., record keeping, reading the patient’s chart, or locating the 
patient), or SAMHSA grant-related activity (e.g., collecting federally mandated performance 
monitoring data). Grant-related activities were not included in the cost estimates because they are 
not a cost of SBIRT per se. To estimate hourly wage rates, job titles and qualifications of 
practitioners were matched with positions in the Bureau of Labor Statistics database (Bureau of 
Labor Statistics, 2009) to obtain the national average wage for each position. Wages were 
multiplied by an estimated overhead and benefits multiplier of 1.2733 (27.33% of wages). The 
median wage within setting was used as a standardized unit cost for labor. The hourly rate for a 
square foot of space was calculated from the national average Class A rental space rate from a 
national real estate analysis firm (Grubb & Ellis Realty Advisors Inc., 2007). Labor costs of each 
SBIRT component were calculated by multiplying the mean time required for direct service 
delivery and support of direct services with the standardized wages. Space costs were calculated 
by multiplying time required for each service and the rental rate per square foot per minute. The 
unit cost of each SBIRT component was calculated by summing of labor and space costs. The 
unit cost for each component of SBIRT was then multiplied by the actual number of sessions that 
each patient received, as indicated by the GPRA discharge data, and an average cost of SBIRT 
per patient was estimated for each setting (Table 3). 
 
 
 
2.5. Health outcomes 
 
Based on the number of patients in each health state, three expected health outcomes were 
calculated. The first effectiveness outcome was the proportion of patients with a good outcome, 
which is defined as not drinking above threshold at follow-up, and hence being in any of the four 
other health states (abstinent, below threshold, new abstinent, and new below threshold). This 
was calculated by dividing the difference between the number of patients with good outcome at 
follow-up and baseline by the number of patients with a good outcome at baseline. The second 
effectiveness outcome was the proportion of patients who improve to below threshold, which is 
defined as a transition from above threshold at baseline to an abstinent or below threshold state at 
follow-up. This was calculated by dividing the difference between the number of patients in the 
above threshold state at baseline and follow-up by the number of patients in the above threshold 
state at baseline. The third health outcome was the QALYs gained, which was the difference 
between follow-up and baseline QALYs. 
 
2.6. Cost-effectiveness analysis 
 
In the CEA, both settings were assessed for dominance (e.g., both more effective and less costly) 
by ranking settings by cost and determining differences in effectiveness. In the absence of one 
setting dominating, an incremental cost-effectiveness ratio (ICER) was computed to estimate the 
additional cost required to achieve one additional unit of outcome. The ICER is the difference in 
costs (C) divided by the difference in mean effectiveness (E), (Cj − Ci)/(Ej − Ei), for strategies j 
and i. In the current study, the best setting is the most effective setting with an ICER that is not 
more than the decision maker’s intrinsic valuation for an additional unit of the outcome 
(Drummond et al., 2005 and Gold et al., 1996). No consensus has been reached on decision 
makers’ willingness to pay in the United States, although a $50,000/QALY benchmark has been 
used in several studies (Grosse, 2008). 
 
Expected costs from a provider perspective were the marginal costs of SBIRT, and from a 
societal perspective were the sum of the costs of SBIRT per patient and the change in social 
costs after SBIRT delivery by drinking state. 
 
2.7. Sensitivity analysis 
 
Probabilistic sensitivity analysis was conducted to incorporate uncertainty in model parameters. 
The quality and quantity of information available were reflected in probability distributions 
assigned to each parameter input in the model where a more diffuse distribution represented a 
higher level of uncertainty in the estimate. Dirichlet, beta, gamma, and normal distributions were 
assigned to the transition probabilities between drinking states, health state utilities, costs of 
SBIRT, and change in social costs parameters, respectively. Monte Carlo simulation was used to 
calculate the combined impact of the model’s various uncertainties (Doubilet, Begg, Weinstein, 
P, & McNeil, 1985). When ICERs were computed, uncertainty in the model was described using 
a cost-effectiveness acceptability curve (CEAC) to graphically show the probability that one 
setting is more cost-effective than the other based on decision makers’ willingness to pay for an 
additional QALY (Briggs et al., 2006 and Drummond et al., 2005). 
 
Two sensitivity analyses were conducted to estimate the impact of changing certain parameters 
on base-case results. 
 
In the first sensitivity analysis, the perspective on costs was the SBIRT payer perspective. The 
SBI Common Procedure and Terminology (CPT) codes (99408, 99409) were used to place a 
monetary value in SBIRT services. The CPT code 99408 reimburses $33.41 for alcohol and/or 
substance abuse structured screening and brief intervention services lasting 15 to 30 min. The 
CPT code 99409 reimburses $65.51 for alcohol and/or substance abuse structured screening and 
brief intervention services greater than 30 min. This does not provide information on the 
breakdown of costs used in the base-case analysis. Therefore, we applied CPT code 99408 to 
screening and BI, and CPT code 99409 to BT. The same value as in the base-case analysis was 
used for RT ($8.61). Under this scenario, the marginal SBIRT cost per patient was $33.43 in the 
ED setting and $65.79 in the outpatient setting. 
 
A second sensitivity analysis assumed a similar number of sessions for each component of 
SBIRT in the two settings. This approach assumed six BI sessions, 12 BT sessions, and one RT 
session for those patients for whom each service was recommended at baseline as a result of 
screening. The number of sessions used was an average of the maximum number of sessions 
specified in each site protocol. This number is not intended to reflect clinical guidance and is 
very specific to the SBIRT programs evaluated. Under this scenario, the marginal SBIRT cost 
per patient was $94.16 (SD 103.85) in the ED setting and $86.30 (SD 73.92) in the outpatient 
setting. 
 
3. Results 
3.1. Base case results 
 
The baseline distribution of positive screen patients presenting to the ED setting was 25% 
abstinent, 18% below threshold, and 57% above threshold; the distribution for the outpatient 
setting was 31% abstinent, 14% below threshold, and 54% above threshold. The base-case 
analysis of 1000 simulations shows that both SBIRT and social costs were lower in the ED 
setting than in the outpatient setting; the majority of the cost savings were societal cost savings 
(Table 4). Delivering SBIRT in an ED setting costs $8.63 less than in an outpatient setting, 
mainly because fewer sessions of BI, and especially BT, were actually delivered in EDs than 
outpatient settings, as previously shown in Table 3. Mean net cost savings for the ED and 
outpatient settings were $531.74 and $217.95, respectively. In terms of effectiveness measures, 
13.8% more patients in the ED setting than the outpatient setting were drinking below threshold 
levels or were abstinent at follow-up. Also, 3.5% more patients in the ED setting than the 
outpatient setting improved their drinking from above threshold levels at baseline to below 
threshold levels or abstinence at follow-up. The greater estimate for the association with drinking 
in the ED setting generated 0.005 more QALY than in the outpatient setting (see Table 4). One 
possible factor contributing to the greater improvements in drinking and QALYs in the ED 
setting is that patients presenting to the ED setting had a lower quality of life than those 
presenting to the outpatient setting (0.815 in ED vs. 0.831 in outpatient), which gives a higher 
potential for improvement from SBIRT services. Overall, for both a provider and social 
perspective, SBIRT in the ED setting dominates the outpatient setting, and an ICER need not be 
calculated. 
 
 
 
3.2. Sensitivity analysis 
 
Two sensitivity analyses varied assumptions on the unit costs of SBIRT services and on the 
number of sessions delivered. When CPT codes were used, the ED setting dominated the 
outpatient setting for all outcome measures. Even though the cost per patient increased, SBIRT 
costs remained higher in the outpatient setting than in the ED setting, because of the higher 
number of services actually received in the outpatient setting. Therefore, the results of the base-
case analysis were robust to the use of CPT reimbursement codes. 
 
In the second sensitivity analysis, assuming the maximum recommended number of BI, BT, and 
RT sessions under a provider perspective, resulted in the ED setting being not just more effective 
but also more expensive. An ICER was computed, and the uncertainty on the overall distribution 
of costs and effects is represented in a CEAC (Fig. 2). The CEAC shows that when the decision 
maker is not willing to pay more than about $1500 per QALY gained, the less expensive setting 
(outpatient) is more cost-effective. As the decision maker is willing to pay more, and therefore 
health gains are more highly valued, the probability that the ED setting is cost-effective 
increases. For threshold values higher than around $4000, there is high certainty that the ED 
setting is the most cost-effective. This is a very low value considering the $50,000/QALY 
benchmark used by decision-makers to determine which intervention represents good value for 
money. 
 
 
 
Under a societal perspective in the second sensitivity analysis, the ED setting dominated the 
outpatient setting. As was found in the base-case analysis, in this case, overall costs were lower 
and effectiveness was higher in the ED setting than in the outpatient setting. SBIRT costs in the 
ED setting were higher because this setting had a larger proportion of patients drinking above 
threshold levels and these patients required more expensive services (like BT). However, overall 
costs were lower because higher service costs were offset by lower social costs. 
 
4. Discussion 
 
This study conducted the first cost-effectiveness analysis comparing SBIRT in ED to SBIRT in 
outpatient settings. We found that delivering SBIRT in an ED setting is potentially effective and 
more cost-effective than the outpatient setting for all simulations of the base-case analysis. 
Consistent with previous studies (Mortimer and Segal, 2005, Saitz et al., 2006 and Solberg et al., 
2008), it was estimated that additional QALYs could be gained at low cost through screening 
plus BI (or/and BT) in either setting. It was also shown that when social costs are included, both 
settings led to net cost savings with the ED being less costly. The QALYs gained in both settings 
(0.013 in ED and 0.008 in outpatient) are slightly below ranges reported elsewhere (Mortimer 
and Segal, 2005, Saitz et al., 2006 and Solberg et al., 2008). However, the findings may not be 
directly comparable, largely because of differences in study periods (short- or long-term 
analysis), modeling methods, intensity and frequency of service, and overall study design 
(observational or randomized). Although the current study found that SBIRT was more cost-
effective in the ED than in the outpatient setting, the finding does not necessarily imply that 
SBIRT should only be implemented in EDs. If decision makers’ preferences and budget allow, 
the results suggest implementing SBIRT in both settings. 
 
In one sensitivity we replaced the number of SBIRT sessions actually received by the average 
number of sessions that grantees had planned to offer. It would seem reasonable to assume that 
with more sessions delivered patients’ outcomes would also improve. However, there is no 
evidence that a higher number of sessions is related to statistically significant better outcomes 
(Kaner et al., 2007). While increasing the number of sessions reflected grantees delivery 
protocol, changing the effectiveness of the intervention, equally or differently in both settings, 
would be speculative. 
 
One characteristic that patients presenting to the ED and outpatient settings had in common was 
screening positive for consuming alcohol above recommended levels. However, as expected, 
patients in each setting differed in demographics and, most importantly, in baseline alcohol 
consumption. This study adopted a pragmatic naturalistic design to capture this variation. 
Adjusting for these differences, to make the patient populations more similar and circumvent 
heterogeneity, would have driven us away from the main objective of the study: comparing the 
delivery of the same intervention – SBIRT – in different settings that naturally serve different 
populations. Our approach maintains the real-world characteristics of the settings and the main 
purpose of the analysis to answer a relevant policy question. 
 
Despite the advantages of a pragmatic naturalistic design, the non-experimental nature of the 
study has the standard disadvantages of observational studies. These include possible regression 
to the mean and selection bias. Relying on pre–post comparisons without a control group cannot 
rule out the possibility that changes observed are driven by regression to the mean or other 
uncontrolled factors rather than the influence attributed to SBIRT. In addition, unobserved 
heterogeneity in the form of setting variation may in part determine the results that suggest that 
ED is more cost-effective in the base case analysis. To some extent, all grantees implemented 
evidence-based practices and a common approach to SBIRT. For example, all grantees used 
evidence-based screening tools to screen for at-risk alcohol use and for the same screening 
instrument all used the instrument’s scoring “zones” of level of alcohol use to determine the 
appropriate SBIRT component (e.g., BI vs. BT). However, aside from measurement errors, there 
might have been unobservable factors influencing assignment that were not only related to 
patients’ substance use (e.g., grantee culture). There were also variations between grantees in 
terms of the screening instrument used and the type of professional delivering each component of 
SBIRT. Our analysis did not account for those variations which might have an impact on both 
the costs and effects of SBI. 
 
The alternative to using observational data, however, is to randomize patients to settings. This 
would likely create an artificial treatment environment as patients could not be feasibly assigned 
to one setting or the other, in part because of the reasons they visit one setting or the other. An 
experimental study would not answer an important question from a public health point of view: 
in which setting is it more cost-effective to deliver SBIRT: the ED or the outpatient setting? If 
decision makers need to decide in which setting they should invest scarce health resources, it 
might be the heterogeneity between settings that justifies delivering SBIRT in one setting rather 
the other. 
 
The analysis faces at least three limitations that have implications for future research. First, even 
though self-report of alcohol use is accurate when collected carefully (Babor et al., 2000 and Del 
Boca and Noll, 2000), as in our study, it remains a concern that social desirability bias could 
have overestimated the benefits of SBIRT. In addition, the measures of drinking – which 
determine the current study health states – do not perfectly align with accepted drinking 
guidelines (NIAAA, 2005). Drinking below the risk threshold in the data does not necessarily 
convey a risk-free drinking level. A finer measure would be needed to disentangle low-risk and 
risky drinking below the current threshold. Nevertheless, the drinking states defined match the 
measures used by SAMHSA, the largest funder of non-research SBIRT programs in the United 
States, to monitor program performance. Second, data on implementation fidelity in the two 
settings were not systematically collected. Therefore, we cannot assess how faithfully each 
setting adhered to SBIRT practices. Third, the study used utilities taken from the peer-reviewed 
literature. Although the utility estimates were based on a U.S. population using well-established 
methods, the weights might not be applicable to SBIRT patients. Future research with greater 
study resources should explore administering a quality of life questionnaire and determining U.S. 
social values to value SBIRT patients’ health states. 
 
In addition to addressing the above limitations, future studies should attempt to replicate the 
findings with other data and build on the research in other ways. An important avenue for future 
research is to understand the long-term cost-effectiveness of SBIRT. Whereas treatment costs are 
incurred immediately, important benefits, such as maintained reductions in chronic disease, are 
realized in the long term (Barbosa, Godfrey and Parrott, 2010 and Barbosa, Taylor, et al., 2010). 
However, limited information is available on the long-term effectiveness of brief alcohol 
interventions (Jonas et al., 2012, Latimer et al., 2010 and Moyer et al., 2002). Two studies 
followed patients for up to 48 months post-intervention (Fleming et al., 1997b, Fleming et al., 
2002, Ockene et al., 1999 and Ockene et al., 2009) and showed modest short-term effects that 
faded over time. Other effectiveness studies show that SBI in outpatient settings is superior to 
SBI in ED settings, in terms of both drinking outcomes and the persistence of those outcomes at 
follow-ups beyond 6 months (Havard et al., 2008, Nilsen et al., 2008 and Schmidt et al., 2014). 
This suggests that, compared with ED settings, outpatient SBIRT may be more cost-effective in 
the long-term. However, without long-term data, this cannot be assessed. To date, no study has 
followed SBI patients for their lifetime, meaning that the long-term effectiveness and cost-
effectiveness of SBI can only be assessed with a modeling framework that extends the approach 
taken in the current study. 
 
Another area for further research is assessing whether screening and BI only would be a 
preferred approach in ED settings, and whether BT should only be offered in a less busy 
outpatient setting. To analyze the effectiveness of the delivery of a different intervention – SBI 
with and without BT – in two different settings, a future study will need to include an 
intervention group (SBI with BT) and a control group (SBI only) within each setting. 
 
Finally, the SBIRT payer perspective used in the second sensitivity analysis considers separable 
budgets for specific health care services, including screening and treatment of behavioral health 
conditions. To adopt a broader health care payer perspective other costs, such as inpatient costs, 
would need to be collected. Further studies should attempt to collect all costs relevant to a payer 
perspective. 
 
Despite its limitations, this paper makes several contributions to the literature on SBI. It presents 
cost and effectiveness data of alcohol SBI in real-world outpatient and ED settings. In contrast, 
most economic evaluations of alcohol SBI have been conducted in a research primary care 
setting (Kraemer, 2007). It also adds to the scarce number of economic evaluations of alcohol 
SBI and the even more scarce number of such evaluations reporting QALYs as an outcome 
measure. Rather than relying on drinking or other outcomes alone, this study incorporates health-
related quality of life. Also, by accounting for statistical uncertainty, the analysis avoids the 
unrealistic assumption that the costs and effects are deterministic in nature. Presenting results 
from both the provider and social perspectives means that results may be useful both to decision 
makers with a narrower, provider focus and to governmental policy makers, who have a broader 
constituency. Finally, by comparing the ED and outpatient settings, the study makes a timely 
contribution to the burgeoning field of comparative effectiveness research. This field of research 
is very much a response to the need to understand how to allocate resources across delivery 
settings in the face of health care reform in the United States. 
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